ENTRY       D00815                      Drug
NAME        Imipramine hydrochloride (JP18/USP);
            Tofranil (TN)
PRODUCT
  GENERIC   IMIPRAMINE HYDROCHLORIDE (A-S Medication Solutions)
            IMIPRAMINE HYDROCHLORIDE (Advanced Rx Pharmacy of Tennessee)
            IMIPRAMINE HYDROCHLORIDE (Advanced Rx Pharmacy of Tennessee)
            IMIPRAMINE HYDROCHLORIDE (AvKARE)
            IMIPRAMINE HYDROCHLORIDE (Bryant Ranch Prepack)
            IMIPRAMINE HYDROCHLORIDE (Bryant Ranch Prepack)
            IMIPRAMINE HYDROCHLORIDE (Bryant Ranch Prepack)
            IMIPRAMINE HYDROCHLORIDE (Bryant Ranch Prepack)
            IMIPRAMINE HYDROCHLORIDE (Golden State Medical Supply)
            IMIPRAMINE HYDROCHLORIDE (Key Therapeutics)
            IMIPRAMINE HYDROCHLORIDE (Leading Pharma)
            IMIPRAMINE HYDROCHLORIDE (NuCare Pharmaceuticals)
            IMIPRAMINE HYDROCHLORIDE (Oxford Pharmaceuticals)
            IMIPRAMINE HYDROCHLORIDE (PD-Rx Pharmaceuticals)
            IMIPRAMINE HYDROCHLORIDE (Par Pharmaceutical)
            IMIPRAMINE HYDROCHLORIDE (Proficient Rx LP)
            IMIPRAMINE HYDROCHLORIDE (Quality Care Products)
            IMIPRAMINE HYDROCHLORIDE (REMEDYREPACK)
            IMIPRAMINE HYDROCHLORIDE (REMEDYREPACK)
            IMIPRAMINE HYDROCHLORIDE (REMEDYREPACK)
            IMIPRAMINE HYDROCHLORIDE (REMEDYREPACK)
            IMIPRAMINE HYDROCHLORIDE (REMEDYREPACK)
            IMIPRAMINE HYDROCHLORIDE (Strides Pharma Science Limited)
            IMIPRAMINE HYDROCHLORIDE (Unit Dose Services)
FORMULA     C19H24N2. HCl
EXACT_MASS  316.1706
MOL_WEIGHT  316.8682
CLASS       Neuropsychiatric agent
             DG01730  Non-selective monoamine reuptake inhibitor
             DG01728  Tricyclic antidepressant
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07982
            Therapeutic category: 1174
            ATC code: N06AA02
            Chemical structure group: DG00928
            Product (DG00928): D00815<JP/US> D08071<US>
EFFICACY    Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)
  DISEASE   Depression [DS:H01646]
COMMENT     Active form of prodrug: Desipramine [DR:D07791]
TARGET      SLC6A4 (HTT) [HSA:6532] [KO:K05037]
            SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
  PATHWAY   hsa04721(6530+6532)  Synaptic vesicle cycle
            hsa04726(6532)  Serotonergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]; CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]
INTERACTION  
STR_MAP     map07027  Antidepressants
            map07213  Dopamine receptor agonists/antagonists
            map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AA Non-selective monoamine reuptake inhibitors
                 N06AA02 Imipramine
                  D00815  Imipramine hydrochloride (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antidepressants
              Tricyclics
               Imipramine
                D00815  Imipramine hydrochloride (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1174  Imipramines
                 D00815  Imipramine hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01730  Non-selective monoamine reuptake inhibitor
               DG00928  Imipramine
                D00815  Imipramine hydrochloride
              DG01728  Tricyclic antidepressant
               DG00928  Imipramine
                D00815  Imipramine hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00928  Imipramine
                D00815  Imipramine hydrochloride
              DG01639  CYP2C19 substrate
               DG00928  Imipramine
                D00815  Imipramine hydrochloride
              DG01644  CYP2D6 substrate
               DG00928  Imipramine
                D00815  Imipramine hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00928  Imipramine
                 D00815  Imipramine hydrochloride
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01730  Non-selective monoamine reuptake inhibitor
               D00815  Imipramine hydrochloride
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D00815  Imipramine hydrochloride (JP18/USP) &lt;JP/US&gt;
                SLC6A4 (HTT)
                 D00815  Imipramine hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00815  Imipramine hydrochloride
              D00815  Imipramine hydrochloride tablets
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00815
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00815
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01730  Non-selective monoamine reuptake inhibitor
               DG00928  Imipramine
              DG01728  Tricyclic antidepressant
               DG00928  Imipramine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00928  Imipramine
              DG01639  CYP2C19 substrate
               DG00928  Imipramine
              DG01644  CYP2D6 substrate
               DG00928  Imipramine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00928  Imipramine
            Prodrugs [br08324.html(DG00928)]
             DG00928
DBLINKS     CAS: 113-52-0
            PubChem: 7847880
            ChEBI: 5882
            LigandBox: D00815
            NIKKAJI: J243.988C
ATOM        22
            1   C1x C    12.8734  -13.8694
            2   C8y C    12.0313  -12.7598
            3   C8y C    12.3665  -11.4030
            4   N1y N    13.6275  -10.8249
            5   C1x C    14.2792  -13.8946
            6   C8y C    14.8811  -11.4472
            7   C8y C    15.1676  -12.8159
            8   C8x C    11.3594  -10.4346
            9   C8x C    10.0174  -10.8227
            10  C8x C     9.6822  -12.1795
            11  C8x C    10.6893  -13.1476
            12  C8x C    16.4988  -13.2530
            13  C8x C    17.5430  -12.3186
            14  C8x C    17.2566  -10.9499
            15  C8x C    15.9252  -10.5128
            16  C1b C    13.6492   -9.4500
            17  C1b C    14.8732   -8.7689
            18  C1b C    16.0416   -9.4684
            19  N1c N    17.2637   -8.7883
            20  C1a C    18.4984   -9.5269
            21  C1a C    17.2857   -7.4200
            22  X   Cl   20.1600  -11.7600
BOND        23
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18    4  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   19  21 1
///
